FEBS Press is a newly established publishing platform for the four journals owned by the not-for-profit Federation of European Biochemical Societies (FEBS). FEBS Press promotes the publication of high-quality journals by scientists and for scientists, with all net income reinvested in molecular life sciences, supporting fellowships, courses, congresses, and other FEBS activities. With over 50 years experience in journal publishing, FEBS Press offers the same high standards of peer review and publishing ethics across both its established and newer journals, with a range of open access options.

The FEBS Journal

For high-quality full-length papers and reviews, with particular focus on biochemistry, molecular biology, structural biology and cell biology.
FEBS Letters

Highly significant research studies that merit urgent publication, and timely reviews of wide interest in the molecular biosciences.
Molecular Oncology

High-impact discoveries, approaches and technical advances in basic, clinical and discovery-driven translational cancer research.
FEBS Open Bio

For rapid open access publication of scientifically sound research articles in the molecular and cellular life sciences.

Click to view our latest issues

  • The FEBS Journal
  • FEBS Letters
  • Molecular Oncology
  • In the Limelight: Glycosphingolipids in Disease cover image

Content from the FEBS Network

The FEBS Network is an online international forum from FEBS for scientists working in the molecular and cellular life sciences which is free to join. Here is a sample of content available.

Early Career Scientist Channel

Viewpoints Channel

Research Channel